POU3F3-related disorder: Defining the phenotype and expanding the molecular spectrum
Rossi, Alessandra; Blok, Lot Snijders; Neuser, Sonja; Klöckner, Chiara; Platzer, Konrad; Faivre, Laurence Olivier; Weigand, Heike; Dentici, Maria L; Tartaglia, Marco; Niceta, Marcello; Alfieri, Paolo; Srivastava, Siddharth; Coulter, David; Smith, Lacey; Vinorum, Kristin; Cappuccio, Gerarda; Brunetti-Pierri, Nicola; Torun, Deniz; Arslan, Mutluay; Lauridsen, Mathilde F; Murch, Oliver; Irving, Rachel; Lynch, Sally A; Mehta, Sarju G; Carmichael, Jenny; Zonneveld-Huijssoon, Evelien; de Vries, Bert; Kleefstra, Tjitske; Johannesen, Katrine M; Westphall, Ian T; Hughes, Susan S; Smithson, Sarah; Evans, Julie; Dudding-Byth, Tracy; Simon, Marleen; van Binsbergen, Ellen; Herkert, Johanna C; Beunders, Gea; Oppermann, Henry; Bakal, Mert; Møller, Rikke S; Rubboli, Guido; Bayat, Allan
(2023) Clinical Genetics, volume 104, issue 2, pp. 186 - 197
(Article)
Abstract
POU3F3 variants cause developmental delay, behavioral problems, hypotonia and dysmorphic features. We investigated the phenotypic and genetic landscape, and genotype-phenotype correlations in individuals with POU3F3-related disorders. We recruited unpublished individuals with POU3F3 variants through international collaborations and obtained updated clinical data on previously published individuals. Trio exome sequencing or single
... read more
exome sequencing followed by segregation analysis were performed in the novel cohort. Functional effects of missense variants were investigated with 3D protein modeling. We included 28 individuals (5 previously published) from 26 families carrying POU3F3 variants; 23 de novo and one inherited from an affected parent. Median age at study inclusion was 7.4 years. All had developmental delay mainly affecting speech, behavioral difficulties, psychiatric comorbidities and dysmorphisms. Additional features included gastrointestinal comorbidities, hearing loss, ophthalmological anomalies, epilepsy, sleep disturbances and joint hypermobility. Autism, hearing and eye comorbidities, dysmorphisms were more common in individuals with truncating variants, whereas epilepsy was only associated with missense variants. In silico structural modeling predicted that all (likely) pathogenic variants destabilize the DNA-binding region of POU3F3. Our study refined the phenotypic and genetic landscape of POU3F3-related disorders, it reports the functional properties of the identified pathogenic variants, and delineates some genotype-phenotype correlations.
show less
Download/Full Text
Keywords: autism, cupped ears, epilepsy, neurodevelopmental disorder, POU3F3, Genetics(clinical), Genetics, Journal Article
ISSN: 0009-9163
Publisher: Wiley-Blackwell
Note: Funding Information: The authors would like to thank the families for their participation. This study makes use of data generated by the DECIPHER community. A full list of centers who contributed to the generation of the data is available from https://deciphergenomics.org/about/stats and via email from contact@deciphergenomics.org . Funding for the DECIPHER project was provided by Wellcome. This study was also, in part, generated within the European Reference Network ITHACA (NBP). This work was in part supported by the Telethon Foundation, Telethon Undiagnosed Diseases Program (TUDP, GSP15001 to Nicola Brunetti‐Pierri). Siddharth Srivastava is funded by NIH‐NINDS (K23NS119666). Allan Bayat is funded by a BRIDGE—Translational Excellence Program grant funded by the Novo Nordisk Foundation, grant agreement number: NNF20SA0064340. Funding Information: The authors would like to thank the families for their participation. This study makes use of data generated by the DECIPHER community. A full list of centers who contributed to the generation of the data is available from https://deciphergenomics.org/about/stats and via email from contact@deciphergenomics.org. Funding for the DECIPHER project was provided by Wellcome. This study was also, in part, generated within the European Reference Network ITHACA (NBP). This work was in part supported by the Telethon Foundation, Telethon Undiagnosed Diseases Program (TUDP, GSP15001 to Nicola Brunetti-Pierri). Siddharth Srivastava is funded by NIH-NINDS (K23NS119666). Allan Bayat is funded by a BRIDGE—Translational Excellence Program grant funded by the Novo Nordisk Foundation, grant agreement number: NNF20SA0064340. Publisher Copyright: © 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
(Peer reviewed)